AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34712343 — intervention group
Group type: EXPERIMENTAL
Intervention: Harpagophytum procumbens (Teltonal) 2 tablets (2*480 mg) daily for one month
Number of subjects: 60
Study 34712343 — intervention group
Group type: COMPARATOR
Intervention: meloxicam 15 mg daily for ten days
Number of subjects: 60
Study 34712343 — intervention group
Group type: EXPERIMENTAL
Intervention: Harpagophytum procumbens (Teltonal)
Number of subjects: 60
Study 34712343 — intervention group
Group type: COMPARATOR
Intervention: meloxicam
Number of subjects: 60
Study 34010183 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB treatment after PCI
Number of subjects: 1905
Study 34010183 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB treatment after CABG
Number of subjects: 1905
Study 34010183 — intervention group
Group type: EXPERIMENTAL
Intervention: No ACEI/ARB treatment after PCI
Number of subjects: 1905
Study 34010183 — intervention group
Group type: EXPERIMENTAL
Intervention: No ACEI/ARB treatment after CABG
Number of subjects: 1905
Study 34010183 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB treatment
Number of subjects: 1905
Study 34010183 — intervention group
Group type: EXPERIMENTAL
Intervention: No ACEI/ARB treatment
Number of subjects: 1905
Study 34949637 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage consent pathway (oral assent followed by informed written consent)
Number of subjects: 0
Study 34949637 — intervention group
Group type: COMPARATOR
Intervention: Standardised information and written record
Number of subjects: 0
Study 32609361 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day
Number of subjects: 77
Study 32609361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 32522591 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 60
Study 32522591 — intervention group
Group type: COMPARATOR
Intervention: Standardized Episodic Thinking (SET)
Number of subjects: 60
Study 32522591 — intervention group
Group type: COMPARATOR
Intervention: DASH diet education
Number of subjects: 60
Study 32522591 — intervention group
Group type: COMPARATOR
Intervention: DASH diet education crossed with EFT
Number of subjects: 60
Study 36000981 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-1014-6470 (60 mg)
Number of subjects: 90
Study 36000981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 32045260 — intervention group
Group type: EXPERIMENTAL
Intervention: PITSTOP mindfulness training video
Number of subjects: 26
Study 32045260 — intervention group
Group type: COMPARATOR
Intervention: Control video on ways to increase physical activity
Number of subjects: 26
Study 33707543 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine Learning methodologies (Random Forests, Extremely Randomized Trees, Boosted Trees, Logistic Regression)
Number of subjects: 0
Study 33707543 — intervention group
Group type: COMPARATOR
Intervention: Traditional multivariate approach (discriminant analysis model)
Number of subjects: 0
Study 32399853 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVN-G3031 (6 mg once daily for multiple doses)
Number of subjects: 100
Study 32399853 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVN-G3031 (up to 20 mg for single doses)
Number of subjects: 100
Study 32399853 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVN-G3031 (multiple doses)
Number of subjects: 100
Study 32399853 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVN-G3031
Number of subjects: 100
Study 35046190 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Number of subjects: 30
Study 35046190 — intervention group
Group type: COMPARATOR
Intervention: Exercises
Number of subjects: 30
Study 34536664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (0.25 ml, 5% cannabidiol, 12.5 mg cannabidiol)
Number of subjects: 39
Study 34536664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 34536664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol
Number of subjects: 39
Study 35944722 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal screening using the Patient Health Questionnaire‐9 (PHQ‐9)
Number of subjects: 12909
Study 35944722 — intervention group
Group type: COMPARATOR
Intervention: Usual school practice of targeted referral for behavior raising a concern for suicide risk
Number of subjects: 12909
Study 33325185 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative metastereotype activation (NMSA)
Number of subjects: 124
Study 33325185 — intervention group
Group type: COMPARATOR
Intervention: Non-NMSA condition
Number of subjects: 124
Study 33954449 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley Recombinant Inbred Diverse Germplasm Population (BRIDG6)
Number of subjects: 6160
Study 33954449 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype-based analysis of HvPpd-H1
Number of subjects: 6160
Study 33954449 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size evaluation for QTL detection
Number of subjects: 6160
Study 36099166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0
Study 36099166 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0
Study 34174349 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration (Icon; DMG)
Number of subjects: 87
Study 34174349 — intervention group
Group type: COMPARATOR
Intervention: Mock (control) treatment
Number of subjects: 87
Study 33095633 — intervention group
Group type: EXPERIMENTAL
Intervention: Certification methods for quantum state preparation and measurement devices
Number of subjects: 0
Study 33095633 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized version of unambiguous state discrimination
Number of subjects: 0
Study 33879769 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP-363856 50 mg
Number of subjects: 12
Study 33879769 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP-363856 10 mg
Number of subjects: 12
Study 33879769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34061684 — intervention group
Group type: EXPERIMENTAL
Intervention: 30SMA (social media applications on smartphones)
Number of subjects: 21
Study 34061684 — intervention group
Group type: EXPERIMENTAL
Intervention: 30VID (videogames)
Number of subjects: 21
Study 34061684 — intervention group
Group type: COMPARATOR
Intervention: CON (coaching videos)
Number of subjects: 21
Study 34061684 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (30SMA, 30VID, CON)
Number of subjects: 21
Study 33550967 — intervention group
Group type: COMPARATOR
Intervention: hsa-miR-129-2 and hsa-miR-889 expression levels in exosomes
Number of subjects: 491
Study 33550967 — intervention group
Group type: EXPERIMENTAL
Intervention: Six independent prognosis-associated miRNAs in exosomes
Number of subjects: 491
Study 33550967 — intervention group
Group type: COMPARATOR
Intervention: Differentially expressed mRNAs (DEGs) and miRNAs (DEMs)
Number of subjects: 491
Study 33550967 — intervention group
Group type: EXPERIMENTAL
Intervention: miRNA-mRNA co-expression network
Number of subjects: 491
Study 33136966 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted muscle reinnervation
Number of subjects: 0
Study 33136966 — intervention group
Group type: COMPARATOR
Intervention: Historical gold standard (excision and burying the involved nerve in muscle)
Number of subjects: 0
Study 35513191 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial discrimination experienced by Black parents at wave 1
Number of subjects: 252
Study 35513191 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent–child conflict at wave 2
Number of subjects: 252
Study 35513191 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial discrimination experienced by Black parents
Number of subjects: 252
Study 35513191 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple outcomes (depression, anxiety, conduct problems)
Number of subjects: 252
Study 33651026 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry storage overnight
Number of subjects: 10
Study 33651026 — intervention group
Group type: COMPARATOR
Intervention: Wet storage overnight
Number of subjects: 10
Study 33651026 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry storage followed by immersion in water for 15 minutes
Number of subjects: 10
Study 33651026 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet storage followed by immersion in water for 15 minutes
Number of subjects: 10
Study 32487179 — intervention group
Group type: EXPERIMENTAL
Intervention: PEERS® social skills intervention
Number of subjects: 150
Study 32487179 — intervention group
Group type: COMPARATOR
Intervention: Active control condition (puberty psychoeducation group training)
Number of subjects: 150
Study 36344851 — intervention group
Group type: EXPERIMENTAL
Intervention: R0 resection and lenvatinib-transarterial chemoembolization (lenvatinib-TACE) sequential therapy
Number of subjects: 83
Study 36344851 — intervention group
Group type: COMPARATOR
Intervention: Other non-curative-intent subsequent treatment
Number of subjects: 83
Study 36344851 — intervention group
Group type: EXPERIMENTAL
Intervention: R0 resection and lenvatinib-TACE sequential therapy
Number of subjects: 83
Study 36344851 — intervention group
Group type: COMPARATOR
Intervention: Non-curative-intent subsequent treatment
Number of subjects: 83
Study 34981493 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil ointment (85% olive oil), applied twice a day for 4 days
Number of subjects: 40
Study 34981493 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment (85% liquid paraffin, similar in color and odor to olive oil ointment), applied twice a day for 4 days
Number of subjects: 40
Study 33998912 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowered Conversations (EC) course
Number of subjects: 159
Study 32200457 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic Hartmann's reversal (SP-HR)
Number of subjects: 44
Study 32200457 — intervention group
Group type: COMPARATOR
Intervention: Multi-port laparoscopic Hartmann's reversal (MP-HR)
Number of subjects: 44
Study 36029646 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengzhan Shengmai (DZSM) capsules
Number of subjects: 150
Study 36029646 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 150
Study 33508236 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial nerve block (SNB) with 1.8 mL of 2% lidocaine and 1:100,000 epinephrine
Number of subjects: 20
Study 33508236 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (CT) with 1.8 mL of 2% lidocaine and 1:100,000 epinephrine
Number of subjects: 20
Study 33508236 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial nerve block (SNB)
Number of subjects: 20
Study 33508236 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (CT)
Number of subjects: 20
Study 32590385 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpulmonary pressure-guided ventilation
Number of subjects: 102
Study 32590385 — intervention group
Group type: COMPARATOR
Intervention: Lung rest strategy
Number of subjects: 102
Study 35272960 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced examiners
Number of subjects: 34
Study 35272960 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice examiners
Number of subjects: 34
Study 35272960 — intervention group
Group type: COMPARATOR
Intervention: Novice vs Experienced examiners
Number of subjects: 34
Study 34014956 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention (CBI)
Number of subjects: 973
Study 34014956 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 973
Study 32553868 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF5633
Number of subjects: 123
Study 32553868 — intervention group
Group type: COMPARATOR
Intervention: Poractant alfa
Number of subjects: 123
Study 32781892 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine-delivered healthy lifestyle programme
Number of subjects: 0
Study 34320935 — intervention group
Group type: EXPERIMENTAL
Intervention: TEPS (Temporal Experience of Pleasure Scale)
Number of subjects: 7410
Study 35896985 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine patients
Number of subjects: 30
Study 35896985 — intervention group
Group type: COMPARATOR
Intervention: Chronic migraine patients
Number of subjects: 30
Study 35896985 — intervention group
Group type: COMPARATOR
Intervention: Episodic migraine patients
Number of subjects: 30
Study 34979245 — intervention group
Group type: COMPARATOR
Intervention: High-definition white light colonoscopy (HDWLE)
Number of subjects: 1203
Study 34979245 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff-assisted colonoscopy (CF)
Number of subjects: 1203
Study 34979245 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CP)
Number of subjects: 1203
Study 32707101 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up 4 Health (FCU4Health) program
Number of subjects: 200
Study 32707101 — intervention group
Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 200
Study 32969563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib (40 mg) plus docetaxel (75 mg/m2 every 3 weeks) and prednisone (10 mg daily)
Number of subjects: 44
Study 32969563 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 weeks) and prednisone (10 mg daily) alone
Number of subjects: 44
Study 35905636 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily massage therapy administered by the mother from 34 weeks' to 40 weeks' corrected age (CA)
Number of subjects: 60
Study 35905636 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 60
Study 34293233 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine plus oral antidepressant
Number of subjects: 223
Study 34293233 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant/placebo
Number of subjects: 223
Study 35395557 — intervention group
Group type: EXPERIMENTAL
Intervention: Light intensity game-based exercise (LIG; 58.64% HRmax)
Number of subjects: 37
Study 35395557 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity game-based exercise (VIG; 89.51% HRmax)
Number of subjects: 37
Study 35395557 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 37
Study 33757566 — intervention group
Group type: EXPERIMENTAL
Intervention: SPRY4-IT1 expression level in esophageal cancer tissues
Number of subjects: 92
Study 33757566 — intervention group
Group type: EXPERIMENTAL
Intervention: High expression of SPRY4-IT1
Number of subjects: 92
Study 33757566 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased expression of SPRY4-IT1
Number of subjects: 92
Study 33757566 — intervention group
Group type: EXPERIMENTAL
Intervention: SPRY4-IT1 expression level
Number of subjects: 92
Study 34508886 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day treatment
Number of subjects: 248
Study 34508886 — intervention group
Group type: COMPARATOR
Intervention: 14-day treatment
Number of subjects: 248
Study 32388584 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated NaHCO3 (0.3 g∙kg‐1 body mass)
Number of subjects: 11
Study 32388584 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin NaHCO3 (0.3 g∙kg‐1 body mass)
Number of subjects: 11
Study 32388584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 36196796 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex 1 ([Fe(L)][Fe(bpb)(CN)2]·CH3OH·0.5H2O)
Number of subjects: 0
Study 36196796 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex 2 ([Fe(L)][Co(bpb)(CN)2]·CH3OH)
Number of subjects: 0
Study 36196796 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex 3 ([(Fe (L))2(4,4'‐bipy)](BPh4)2)
Number of subjects: 0
Study 36196796 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex 4 ([Fe(L)(py)](BPh4))
Number of subjects: 0
Study 36196796 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex 5 ([Fe(L)(dmap)](BPh4))
Number of subjects: 0
Study 32954451 — intervention group
Group type: EXPERIMENTAL
Intervention: Cypermethrin (CYP) treatment at 10 μg mL‐1
Number of subjects: 0
Study 32954451 — intervention group
Group type: EXPERIMENTAL
Intervention: Cypermethrin (CYP) treatment
Number of subjects: 0
Study 32954451 — intervention group
Group type: COMPARATOR
Intervention: Control (CK)
Number of subjects: 0
Study 32532772 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (AUS 52%)
Number of subjects: 668
Study 32532772 — intervention group
Group type: EXPERIMENTAL
Intervention: Community rehabilitation (UK 65%)
Number of subjects: 668
Study 32532772 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation then community rehabilitation
Number of subjects: 668
Study 32532772 — intervention group
Group type: EXPERIMENTAL
Intervention: Home with no rehabilitation
Number of subjects: 668
Study 32532772 — intervention group
Group type: EXPERIMENTAL
Intervention: Working prior to stroke (n=228)
Number of subjects: 668
Study 33349011 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg+H2
Number of subjects: 37
Study 33349011 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 37
Study 33349011 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg and Mg+H2
Number of subjects: 37
Study 32393436 — intervention group
Group type: EXPERIMENTAL
Intervention: Collective navigation skills of longhorn crazy ants
Number of subjects: 0
Study 32393436 — intervention group
Group type: EXPERIMENTAL
Intervention: Collective sensing range extension
Number of subjects: 0
Study 32393436 — intervention group
Group type: EXPERIMENTAL
Intervention: Percolation theory application
Number of subjects: 0
Study 33884564 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplatzer Amulet
Number of subjects: 0
Study 33884564 — intervention group
Group type: COMPARATOR
Intervention: Watchman/FLX
Number of subjects: 0
Study 35224871 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) for 35 min, with intervals increasing from 50% heart rate reserve to 85–90% for 2 min.
Number of subjects: 25
Study 35224871 — intervention group
Group type: COMPARATOR
Intervention: Moderate Continuous Intensity (MCI) exercise at 50% of heart rate reserve for 35 min.
Number of subjects: 25
Study 33317345 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 695501
Number of subjects: 317
Study 33317345 — intervention group
Group type: COMPARATOR
Intervention: adalimumab RP
Number of subjects: 317
Study 32255542 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg esaxerenone
Number of subjects: 55
Study 32255542 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg esaxerenone
Number of subjects: 55
Study 32255542 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg moxifloxacin
Number of subjects: 55
Study 32255542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 35085663 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen immunotherapy (subcutaneous and sublingual) continued for a minimum of 3 years
Number of subjects: 0
Study 35085663 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy for seasonal rhinitis
Number of subjects: 0
Study 35085663 — intervention group
Group type: EXPERIMENTAL
Intervention: Mite sublingual immunotherapy
Number of subjects: 0
Study 33389322 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored program to increase positive affect and decrease depressive symptoms
Number of subjects: 8
Study 33389322 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored program to increase gender empowerment
Number of subjects: 8
Study 33389322 — intervention group
Group type: EXPERIMENTAL
Intervention: Program delivery timing suggestion
Number of subjects: 8
Study 33181557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg·kg‐1
Number of subjects: 159
Study 33181557 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol 30 mg·kg‐1
Number of subjects: 159
Study 33181557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg·kg‐1 + Propacetamol 30 mg·kg‐1
Number of subjects: 159
Study 32472893 — intervention group
Group type: EXPERIMENTAL
Intervention: Le Fort III distraction osteogenesis without coronal incision
Number of subjects: 22
Study 32472893 — intervention group
Group type: COMPARATOR
Intervention: Le Fort III distraction osteogenesis with coronal incision
Number of subjects: 22
Study 33415472 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Comprehensive Behavioral Intervention for Tics (group-CBIT)
Number of subjects: 46
Study 33415472 — intervention group
Group type: COMPARATOR
Intervention: Group Educational Intervention for Tics (group-EIT)
Number of subjects: 46
Study 32232546 — intervention group
Group type: EXPERIMENTAL
Intervention: High dairy intake (HD) (≥ 4 servings/day)
Number of subjects: 10
Study 32232546 — intervention group
Group type: COMPARATOR
Intervention: Adequate dairy intake (AD) (≤ 2 servings/day)
Number of subjects: 10
Study 32232546 — intervention group
Group type: EXPERIMENTAL
Intervention: High dairy intake (HD)
Number of subjects: 10
Study 32232546 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive GM signature
Number of subjects: 10
Study 32787932 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Interpersonal Therapy (IPT) adapted for adolescents; delivered in secondary schools by school nurses and lay community members; includes parental engagement components and locally acceptable terms for mental illness.
Number of subjects: 126
Study 35546458 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut cream 50%
Number of subjects: 60
Study 35546458 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% ointment
Number of subjects: 60
Study 34247834 — intervention group
Group type: COMPARATOR
Intervention: Real world data as a comparator for single-arm treatment trials
Number of subjects: 0
Study 34247834 — intervention group
Group type: COMPARATOR
Intervention: External controls
Number of subjects: 0
Study 35230052 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0
Study 35230052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze at the face and neck areas of each image for 10 seconds
Number of subjects: 80
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention directed toward the eye
Number of subjects: 80
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention directed toward the nose
Number of subjects: 80
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention directed toward the cheek
Number of subjects: 80